261 related articles for article (PubMed ID: 3122515)
1. Microflora of cervical and vaginal secretion in women using copper- and norgestrel-releasing IUCDs.
Ulstein M; Steier AJ; Hofstad T; Digranes A; Sandvei R
Acta Obstet Gynecol Scand; 1987; 66(4):321-2. PubMed ID: 3122515
[TBL] [Abstract][Full Text] [Related]
2. The effect of a copper intra-uterine contraceptive device on the microbial ecology of the female genital tract.
Elhag KM; Bahar AM; Mubarak AA
J Med Microbiol; 1988 Apr; 25(4):245-51. PubMed ID: 3357191
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
[TBL] [Abstract][Full Text] [Related]
4. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
[TBL] [Abstract][Full Text] [Related]
5. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
Nilsson CG; Allonen H; Diaz J; Luukkainen T
Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
[TBL] [Abstract][Full Text] [Related]
6. Effects of various IUDs on the composition of cervical mucus.
Jonsson B; Landgren BM; Eneroth P
Contraception; 1991 May; 43(5):447-58. PubMed ID: 1914458
[TBL] [Abstract][Full Text] [Related]
7. Influence of removal of intrauterine contraceptive devices on colonisation of the cervix by actinomyces-like organisms.
Mao K; Guillebaud J
Contraception; 1984 Dec; 30(6):535-44. PubMed ID: 6529911
[TBL] [Abstract][Full Text] [Related]
8. Endometrial morphological changes in IUD users: a review.
Sheppard BL
Contraception; 1987 Jul; 36(1):1-10. PubMed ID: 3117492
[TBL] [Abstract][Full Text] [Related]
9. The impact of copper-containing and levonorgestrel-releasing intrauterine contraceptives on cervicovaginal cytology and microbiological flora: a prospective study.
Erol O; Simavlı S; Derbent AU; Ayrım A; Kafalı H
Eur J Contracept Reprod Health Care; 2014 Jun; 19(3):187-93. PubMed ID: 24738915
[TBL] [Abstract][Full Text] [Related]
10. Five years' experience with levonorgestrel-releasing IUDs.
Luukkainen T; Allonen H; Haukkamaa M; Lähteenmäki P; Nilsson CG; Toivonen J
Contraception; 1986 Feb; 33(2):139-48. PubMed ID: 3084167
[TBL] [Abstract][Full Text] [Related]
11. Ovarian function during use of a levonorgestrel-releasing IUD.
Barbosa I; Bakos O; Olsson SE; Odlind V; Johansson ED
Contraception; 1990 Jul; 42(1):51-66. PubMed ID: 2117516
[TBL] [Abstract][Full Text] [Related]
12. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS.
Sivin I; Stern J; Coutinho E; Mattos CE; el Mahgoub S; Diaz S; Pavez M; Alvarez F; Brache V; Thevenin F
Contraception; 1991 Nov; 44(5):473-80. PubMed ID: 1797462
[TBL] [Abstract][Full Text] [Related]
13. Early chorionic activity in women bearing inert IUD, copper IUD and levonorgestrel-releasing IUD.
Videla-Rivero L; Etchepareborda JJ; Kesseru E
Contraception; 1987 Aug; 36(2):217-26. PubMed ID: 3123135
[TBL] [Abstract][Full Text] [Related]
14. Cervical carcinogenesis and contraception.
Misra JS; Engineer AD; Das K; Tandon P
Diagn Cytopathol; 1991; 7(4):346-52. PubMed ID: 1935511
[TBL] [Abstract][Full Text] [Related]
15. The incidence of actinomyces-like organisms in Papanicolaou-stained smears of copper- and levonorgestrel-releasing intrauterine devices.
Merki-Feld GS; Lebeda E; Hogg B; Keller PJ
Contraception; 2000 Jun; 61(6):365-8. PubMed ID: 10958879
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
17. Levonorgestrel levels in serum and uterine flushings in women bearing LNG-Cu-IUD.
Shi JP; Wu XR
J Tongji Med Univ; 1993; 13(2):126-8. PubMed ID: 8230357
[TBL] [Abstract][Full Text] [Related]
18. The pathology of intra-uterine contraceptive devices.
Buckley CH
Curr Top Pathol; 1994; 86():307-30. PubMed ID: 8162713
[TBL] [Abstract][Full Text] [Related]
19. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
Sturridge F; Guillebaud J
Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
[TBL] [Abstract][Full Text] [Related]
20. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
